| 07/30 | Seqirus Presents New Safety Data Demonstrating Safety of Cell-Based Seasonal .. | CI |
| 07/29 | EISAI : Biogen, Eisai report design of real-world study of Alzheimer's treatment | RE |
| 07/29 | Biogen and Eisai Announce Design of ADUHELM ICARE AD-US Study, the First Real.. | CI |
| 07/29 | Exclusive - AstraZeneca exploring options for COVID-19 vaccine business - exe.. | RE |
| 07/29 | AstraZeneca Lifts 2021 Guidance After Alexion Acquisition; Posts Lower 2Q Pro.. | DJ |
| 07/29 | AstraZeneca 2Q Net Profit Dropped Despite Higher Revenue; Raises Guidance | DJ |
| 07/27 | CSL : Seqirus says it can supply 60 mln doses of influenza vaccines for U.S. flu.. | RE |
| 07/27 | BIOGEN : withdrew Aduhelm paper after JAMA asked for edits - Axios | RE |
| 07/27 | CSL : Seqirus says can supply 60 mln doses of influenza vaccines for U.S. flu se.. | RE |
| 07/27 | BIOGEN : Canaccord Genuity Adjusts Biogen's Price Target to $423 From $359, Reit.. | MT |
| 07/27 | Samsung Biologics Co.,Ltd. Provides Dividend Guidance for the Year 2021 | CI |
| 07/27 | Samsung Biologics Co.,Ltd. Reports Earnings Results for the Second Quarter En.. | CI |
| 07/26 | Biogen Inc. and Ionis Pharmaceuticals, Inc. Announces Positive Topline Clinic.. | CI |
| 07/26 | Wuxi Biologics Receives Commercial Manufacturing License from German Health A.. | CI |
| 07/26 | ASTRAZENECA : EU regulator backs AstraZeneca drug for rare blood disorder in chi.. | RE |
| 07/26 | ASTRAZENECA : EU regulator endorses AstraZeneca drug for rare blood disorder in .. | RE |
| 07/23 | BIOGEN : Morgan Stanley Adjusts Biogen's Price Target to $455 from $453, Keeps O.. | MT |
| 07/23 | BIOGEN : RBC Cuts Price Target on Biogen to $341 From $361, Reiterates Sector Pe.. | MT |
| 07/23 | ANALYST RECOMMENDATIONS : Apple, Aviva, Biogen, Comerica Incorporated, Tesla... | |
| 07/23 | Australian shares end at record high on healthcare, tech boost | RE |
| 07/23 | DGAP-NEWS : Il settore delle biotecnologie -2- | DJ |
| 07/23 | DGAP-NEWS : Il settore delle biotecnologie archivia un secondo trimestre all'ins.. | DJ |
| 07/23 | PRESS RELEASE : Solid second quarter for the -2- | DJ |
| 07/23 | PRESS RELEASE : Solid second quarter for the biotech industry - BB Biotech raise.. | DJ |
| 07/22 | BIOGEN : Wedbush Raises Biogen's Price Target to $314 From $312, Maintains Neutr.. | MT |
| 07/22 | Biogen Raises Revenue Guidance, Reiterates Earnings Guidance | DJ |
| 07/22 | Biogen Posts 2Q Sales, Earnings Declines on Lower Multiple-Sclerosis Drug Rev.. | DJ |
| 07/22 | Biogen Inc. Reports Impairment Charges for the Three Months Ended June 30, 20.. | CI |
| 07/22 | Tranche Update on Biogen Inc.'s Equity Buyback Plan announced on October 21, .. | CI |
| 07/22 | Biogen Inc. Reports Earnings Results for the Second Quarter Ended June 30, 20.. | CI |
| 07/22 | Biogen Inc. Revises Earnings Guidance for the Year 2021 | CI |
| 07/22 | Biogen Inc. Announces Aduhelm Became the First Approved Treatment to Address .. | CI |
| 07/22 | Alexion Pharmaceuticals, Inc. Announces Board Cessations | CI |
| 07/22 | Biogen Research Head Defends Alzheimer's Drug | DJ |
| 07/21 | Mirimus, Inc. Forms Strategic Collaboration with Biogen Inc. to Develop RNAi-.. | CI |
| 07/21 | BIOGEN : Anthem says COVID-19 costs could rise in coming quarters from variants | RE |
| 07/21 | BIOGEN : Alzheimer's drug slow to take off as U.S. Medicare wrestles with covera.. | RE |
| 07/21 | ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P TMI Index | CI |
| 07/21 | ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from INDUSTRIALS | CI |
| 07/21 | ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P 500 Health Care | CI |
| 07/21 | ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P Composite 1500 | CI |
| 07/21 | ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P Global 1200 | CI |
| 07/21 | ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from FTSE All-World Index | CI |
| 07/21 | ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P 500 EQUAL WEIGHTED | CI |
| 07/21 | ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P Global BMI Index | CI |
| 07/21 | ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P Biotechnology Sele.. | CI |
| 07/21 | ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P 500 | CI |
| 07/21 | ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P 500 Growth | CI |
| 07/21 | ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from NASDAQ Composite Index | CI |
| 07/21 | ALEXION PHARMACEUTICALS, INC.(NASDAQ : ALXN) dropped from S&P 500 Value | CI |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
